Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Maintenance Treatment by Ribavirin to a Placebo, After an Initial One-year Treatment With Pegylated Interferon-α2a - Ribavirin Association in Hepatitis C Viral Recurrence After Liver Transplantation

NCT00151580 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT00151580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00151580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Maintenance Treatment by Ribavirin to a Placebo, After an Initial One-year Treatment With Pegylated Interferon-α2a - Ribavirin Association in Hepatitis C Viral Recurrence After Liver Transplantation
Lead sponsor
Rennes University Hospital
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2002
Completion date
July 31, 2006
Enrollment
200 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, liver transplantation